Description: A rare, benign, but locally destructive vascular and fibrous neoplasm that specifically arises in the head and neck region.
Clinical Presentation: Classically affects adolescent to young adult males, who typically present with chronic and recurrent epistaxis (nosebleeds), nasal obstruction, headaches, and sometimes visual or auditory disturbances (diplopia, tinnitus, deafness).
Location: Most frequently originates in the posterolateral nasopharynx.
Syndromic Association: Highly associated with Familial Adenomatous Polyposis (FAP) syndrome (Gardner's syndrome).
Prognosis: Good with surgical management, though localized recurrence is relatively common (~25% of cases) and typically happens within the first two years following excision.
Genetic predisposition (e.g., FAP/APC gene mutations) → Alteration of the Wnt/beta-catenin (β-catenin) signaling pathway → Abnormal nuclear accumulation of β-catenin → Uncontrolled proliferation of fibroblastic stromal cells and rich vascular networks → Formation of an expansile, highly vascularized nasopharyngeal mass.
Note: The extraordinarily rich and delicate vascular network directly explains the classic clinical symptom of severe, recurrent epistaxis.
Architecture: A biphasic proliferation composed of a prominent vascular network embedded within a fibrocollagenous stroma.
Vessels: Thin-walled blood vessels of wildly variable sizes, ranging from delicate capillary-like networks to large, ectatic, slit-like (staghorn) spaces. The vessels are lined by a single layer of flattened to plump endothelial cells.
Stroma: The intervening stroma is composed of bland, plump fibrous cells and features scattered, frequent mast cells.
Atypia and Mitoses: Tumor cells lack cytologic atypia, and mitotic figures are rare.
Board Pearls & Pitfalls: Because these tumors bleed profusely, patients often undergo pre-surgical embolization. As a result, the stroma frequently develops prominent secondary myxoid degeneration and necrosis, which should not be misinterpreted as a myxoid malignancy.
Key Immunohistochemistry (≤5 markers):
Androgen Receptor (AR) (+): Expressed in the stromal cells.
Nuclear β-catenin (+): Expressed in the stromal cells.
Smooth Muscle Actin (SMA), Desmin, and CD34 (-): The stromal cells are negative for these markers (though CD34 will naturally highlight the background endothelial cells).
Molecular Alterations: Driven by APC mutations and Wnt pathway dysregulation, linking the tumor to FAP.
H&E Diagnostic Status: H&E morphology combined with classic clinical demographics (adolescent male with nosebleeds) is usually diagnostic; however, nuclear β-catenin and AR can be utilized for confirmation in ambiguous cases.
Solitary Fibrous Tumor (SFT):
Distinction: While both lesions can feature a prominent, branching "staghorn" vascular network set within a collagenous stroma, SFT typically displays a characteristic "patternless pattern" of ovoid to spindled cells. Immunohistochemically, SFT is uniquely driven by a NAB2-STAT6 gene fusion and will show strong nuclear positivity for STAT6 and diffuse positivity for CD34, whereas the stromal cells of nasopharyngeal angiofibroma are negative for STAT6 and CD34 but positive for nuclear β-catenin and Androgen Receptor (AR).
Glomangiopericytoma:
Distinction: Features a diffuse, patternless spindle cell proliferation with a subepithelial clearing (Grenz zone) and perivascular hyalinization. While it also expresses nuclear β-catenin, it is distinguished by positive expression for SMA and nuclear cyclin D1, and it lacks AR expression.
Lobular Capillary Hemangioma (Pyogenic Granuloma):
Distinction: Characterized by discrete lobules of capillary proliferation separated by fibrous septa, often with surface ulceration and acute inflammation. It lacks the thick fibrocollagenous stroma of an angiofibroma and is negative for nuclear β-catenin and AR.
Biphenotypic Sinonasal Sarcoma:
Distinction: A cellular, infiltrative spindle cell tumor often featuring trapped respiratory glands. It lacks prominent gaping vascular spaces and will demonstrate positive staining for S100 and SMA.
Sinonasal Inflammatory Polyp:
Distinction: Displays an edematous stroma with thick basement membranes and a mixed inflammatory infiltrate (eosinophils, lymphocytes, plasma cells). It lacks the specific staghorn vascular pattern and is negative for AR and nuclear β-catenin.
Nasopharynx, mass, excision:
Nasopharyngeal angiofibroma.
Comment: The sections demonstrate a benign neoplasm composed of an unencapsulated proliferation of variably sized, thin-walled vascular channels set within a fibrocollagenous stroma with scattered mast cells. Focal myxoid changes consistent with pre-operative embolization effect are noted.